theory clinical_1_0
imports Main

begin

typedecl entity
typedecl event

consts
  Olaparib :: "entity ⇒ bool"
  Rucaparib :: "entity ⇒ bool"
  PARP1Inhibitor :: "entity ⇒ bool"
  ProstateCancerPatient :: "entity ⇒ bool"
  UseFor :: "entity ⇒ entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  PARP1Inhibition :: "entity ⇒ bool"
  SyntheticLethality :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"  (* Renamed to avoid conflict *)
  Cause :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  Cell :: "entity ⇒ entity"
  Mechanism :: "entity ⇒ bool"
  Singular :: "entity ⇒ bool"
  Repair :: "event ⇒ bool"
  Damage :: "entity ⇒ bool"
  Cumulative :: "entity ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  DNA :: "entity ⇒ entity"
  TreatmentOption :: "entity ⇒ bool"
  For :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Olaparib is a PARP1 inhibitor licenced for use in prostate cancer patients. *)
axiomatization where
  explanation_1: "∀x y. Olaparib x ∧ PARP1Inhibitor x ∧ ProstateCancerPatient y ⟶ UseFor x y"

(* Explanation 2: Rucaparib is a PARP1 inhibitor licenced for use in prostate cancer patients. *)
axiomatization where
  explanation_2: "∀x y. Rucaparib x ∧ PARP1Inhibitor x ∧ ProstateCancerPatient y ⟶ UseFor x y"

(* Explanation 3: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)
axiomatization where
  explanation_3: "∀x y z e1 e2 e3 w v. Patient x ∧ LossOfBRCA2 x ∧ PARP1Inhibition y ∧ SyntheticLethality z ∧ Benefit e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ Cause e2 ∧ Agent e2 z ∧ Rely e3 ∧ Agent e3 (Cell x) ∧ Mechanism w ∧ Singular w ∧ Repair e3 ∧ Damage v ∧ Cumulative v ∧ To v (DNA x)"

theorem hypothesis:
  assumes asm: "Patient z"
  (* Hypothesis: There are two potential treatment options for this patient. *)
  shows "∃x y. TreatmentOption x ∧ TreatmentOption y ∧ Patient z ∧ For x z ∧ For y z"
proof -
  (* From the premise, we have the known information about the patient. *)
  from asm have "Patient z" by blast
  (* Explanation 1 and Explanation 2 provide information about Olaparib and Rucaparib being used for prostate cancer patients. *)
  (* We can consider Olaparib and Rucaparib as potential treatment options. *)
  (* Since both are licensed for use in prostate cancer patients, they can be considered treatment options for the patient z. *)
  have "TreatmentOption Olaparib ∧ TreatmentOption Rucaparib" sledgehammer
  (* Since Olaparib and Rucaparib are treatment options, and they are used for prostate cancer patients, we can infer they are for patient z. *)
  then have "For Olaparib z ∧ For Rucaparib z" sledgehammer
  (* Therefore, there exist two treatment options for the patient z. *)
  then show ?thesis sledgehammer
qed

end
